Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04694755Phase 1Unknown
Phase 1, randomised, double-blind trial in chronic respiratory failure and chronic obstructive pulmonary disease (COPD) (4 arms), sponsored by Henan University of Chinese Medicine. Primary endpoints: Frequency of acute exacerbation at 52 weeks and Duration of acute exacerbation at 52 weeks. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04694755.